Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artiva Biotherapeutics Inc ARTV

Healthcare Biotechnology
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. The Company's product candidates are derived from donor cells (allogeneic) rather than a patient's own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a... see more

Recent & Breaking News (NDAQ:ARTV)

    Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    GlobeNewswire November 12, 2024

    Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

    GlobeNewswire November 11, 2024

    Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

    GlobeNewswire October 22, 2024

    Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

    GlobeNewswire September 10, 2024

    Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    GlobeNewswire August 29, 2024